| Product NDC: | 68180-317 |
| Proprietary Name: | Imipramine Pamoate |
| Non Proprietary Name: | Imipramine Pamoate |
| Active Ingredient(s): | 150 mg/1 & nbsp; Imipramine Pamoate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68180-317 |
| Labeler Name: | LUPIN PHARMACEUTICALS INC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090444 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100416 |
| Package NDC: | 68180-317-06 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (68180-317-06) |
| NDC Code | 68180-317-06 |
| Proprietary Name | Imipramine Pamoate |
| Package Description | 30 CAPSULE in 1 BOTTLE (68180-317-06) |
| Product NDC | 68180-317 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Imipramine Pamoate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100416 |
| Marketing Category Name | ANDA |
| Labeler Name | LUPIN PHARMACEUTICALS INC |
| Substance Name | IMIPRAMINE PAMOATE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Tricyclic Antidepressant [EPC] |